C Difficile Quality Of Life Survey Cdiff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New PUNCH CD3 analyses show patients who were treated with live fecal microbiota therapy improved their gut health at 8 weeks which correlated with improved quality-of-life scores.

British columbiaPaul feuerstadtYale university school of medicineGastroenterology centerAmerican college of gastroenterologyC difficile quality of life survey cdiffAmerican collegeScientific meetingYale university schoolLife surveyPunch cd3C difficileC diff